Approvals/TGA/IRBESARTAN/HCT SANDOZ 300/12.5 irbesartan 300 mg/hydrochlorothiazide 12.5 mg film-coated tablet bottle

Approved

STANDARD

IRBESARTAN/HCT SANDOZ 300/12.5 irbesartan 300 mg/hydrochlorothiazide 12.5 mg film-coated tablet bottle

Sandoz Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 8f1fb5a533b11ec2
Product Name: IRBESARTAN/HCT SANDOZ 300/12.5 irbesartan 300 mg/hydrochlorothiazide 12.5 mg film-coated tablet bottle
Artg Id: 174730
Artg Name: IRBESARTAN/HCT SANDOZ 300/12.5 irbesartan 300mg / hydrochlorothiazide 12.5mg film-coated tablet bottle
Sponsor: Sandoz Pty Ltd
Company Detail Path: /organization/sandoz-pty-ltd
Artg Date: 2011-10-28
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

8f1fb5a533b11ec2

Type

Standard